75000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Business and Liquidity link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Cash and Cash Equivalents link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Accrued and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Share-based Compensation Plans link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Fair Value Measurement link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Segments link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Cash and Cash Equivalents (Tables) link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Accrued and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Share-based Compensation Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Business and Liquidity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Net Loss Per Share - Schedule of Anti-dilutive Securities (Details) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Cash and Cash Equivalents - Summary of Cash Equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Accrued and Other Current Liabilities - Summary of Accrued liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Accrued and Other Current Liabilities - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Share-based Compensation Plans - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Share-based Compensation Plans - Summary of Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Share-based Compensation Plans - Summary of Non-vested Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Share-based Compensation Plans - Summary of Stock Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Fair Value Measurement - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Equity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Segments - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Segments - Summary of Selected Financial Information Related to the Company's Single Reportable Segment (Details) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vested, Weighted Average Grant Date Fair Value Sales Agreement Sales Agreement [Member] Sales agreement. Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Share Based Compensation Arrangement by Share Based Payment Award Plan Modification Remaining Vesting Period Share based compensation arrangement by share based payment award plan modification remaining vesting period. Share based payment award plan modification remaining vesting period Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accounts Payable, Total Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosures - non-cash activities: Plan Name [Axis] Dr. Buell [Member] Dr. Buell Dr. Buell. Equity [Abstract] Entity Current Reporting Status Entity Current Reporting Status Operating Expenses [Abstract] Operating expenses: Fair Value, Inputs, Level 2 [Member] Level 2 Common Stock, Shares Authorized Common stock, shares authorized Document Fiscal Period Focus Document Fiscal Period Focus 2021 Employee Stock Purchase Plan Two Thousand Twenty One Employee Stock Purchase Plan [Member] 2021 Employee Stock Purchase Plan. Entity Shell Company Entity Shell Company Cash and Cash Equivalent Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Common Stock, Shares, Issued Common stock, shares issued Employee Bonus. Employee Bonus [Member] Employee Bonus Statement [Table] Statement [Table] Increase (Decrease) in Prepaid Expense Prepaid expenses Additional compensation received Additional Compensation Received Additional compensation received. Long-Term Purchase Commitment, Category of Item Purchased [Domain] Long-Term Purchase Commitment, Category of Item Purchased Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant-date fair values of options granted Statement [Line Items] Statement [Line Items] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Expired, Weighted Average Exercise Price Entity Filer Category Entity Filer Category Total liabilities and stockholders' deficit Liabilities and Equity Debt Instrument [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable at March 31, 2026, Weighted Average Exercise Price Other liabilities, current. Other Liabilities Current [Table] Other Liabilities Current [Table] Cash and Cash Equivalents, Fair Value Disclosure Estimated Fair Value Subsequent Event [Line Items] Stock Options Atlant Clinical Ltd. Atlant Clinical Ltd [Member] Atlant Clinical Ltd [Member] Forgiveness of Related Party Liability Forgiveness of Related Party Liability [Member] Forgiveness of related party liability member. Additional Paid in Capital, Common Stock Additional paid-in capital Debt Instrument, Interest Rate During Period Convertible debt, annual interest rate Related Party [Member] Related Party Significant Accounting Policies [Text Block] Significant Accounting Policies Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award Stock option grants, term Schedule of Cash and Cash Equivalents [Table Text Block] Summary of Cash Equivalents Number of shares options, granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Options, Granted Increase (Decrease) in Other Operating Assets and Liabilities, Net Other operating assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net, Total Change in fair value of related party note Change in fair value of related party note. Business and liquidity. Business And Liquidity [Text Block] Business and Liquidity Directors or Officers [Member] Directors or officers. Directors or Officers Earnings Per Share, Basic Basic net loss per common share Earnings Per Share, Basic, Total Exercise of stock options and employee share purchases, Shares Stock Issued During Period Shares Stock Options Exercised And Employee Stock Purchase Plan Stock issued during period shares stock options exercised and employee stock purchase plan. Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total Foreign currency translation gain (loss) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Options, Outstanding at Ending Balance Options, Outstanding at Beginning Balance Outstanding options Stock Issued Issuance of common stock, $0.00001 par value, for payment of certain employee bonuses Issuance of common stock, $0.00001 par value Compensation paid Salary and Wage, Officer, Excluding Cost of Good and Service Sold Liabilities, Current Total current liabilities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Salary and Wage, Excluding Cost of Good and Service Sold, Total Salary and Wage, Excluding Cost of Good and Service Sold Compensation paid Adjustment to additional paid-in capital issuance of related party note. Adjustment to additional paid-in capital issuance of related party note Issuance of related party note Notes Payable, Fair Value Disclosure Fair value of note Stock Issued During Period, Value, Restricted Stock Award, Forfeitures Forfeiture of restricted stock Other Liabilities, Current [Abstract] STOCKHOLDERS' DEFICIT Equity, Attributable to Parent [Abstract] Entity Small Business Entity Small Business Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit), Total Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Options, Forfeited Sale of Stock, Price Per Share Purchase price per share Treasury Stock, Retired, Cost Method, Amount Retirement of treasury shares related to employee withholding Share-Based Payment Arrangement [Text Block] Share-based Compensation Plans Unusual Risk or Uncertainty, Nature [Domain] Amendment Flag Amendment Flag Premium percentage Sale of Stock premium percentage Sale of stock premium percentage. Treasury Stock, Shares, Retired Retirement of treasury shares, share Retirement of treasury shares, share LIABILITIES AND STOCKHOLDERS' DEFICIT Liabilities and Equity [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net cash used in operating activities Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Common Stock [Member] Common Stock Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted, Weighted Average Exercise Price Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Equipment, net of accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Debt Instrument, Interest Rate, Effective Percentage Market interest rate Convertible debt, effective interest rate Entity Address, Address Line One Entity Address, Address Line One Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV Earnings Per Share [Abstract] Per common share data: Supplemental Cash Flow Information [Abstract] Supplemental cash flow information: Loss Contingency [Abstract] Minimum value of listed securities Minimum value of listed securities. Minimum Value of Listed Securities Document Type Document Type Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative Entity Central Index Key Entity Central Index Key Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net increase (decrease) in cash and cash equivalents Subsequent Event Type [Domain] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Total anti-dilutive securities Stock Repurchased and Retired During Period, Shares Share retirement, Shares Share retirement, Shares APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Recognition of parent stock options Common Stock, Par or Stated Value Per Share Common stock, par value Operating Costs and Expenses, Total Operating Costs and Expenses Expenses from transactions with related party Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Outstanding at March 31, 2026, Weighted Average Remaining Contractual Term Deconsolidation, Gain (Loss), Amount Gain on deconsolidation Gain on deconsolidation of foreign subsidiary Gain on deconsolidation Clinical research services. Clinical Research Services Clinical research services Stock option exercises Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Option exercises, Shares Options, Exercised Debt Disclosure [Abstract] Repayment of related party note Repayments of Related Party Debt Service agreement notice period. Service Agreement Notice Period Service agreement notice period Accrued liabilities Total Accrued Liabilities, Current Adjustments to additional paid in capital share based compensation stock options grant and recognition. Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Grant And Recognition Grant and recognition of stock options Stock Issued During Period, Value, Restricted Stock Award, Gross Vesting of nonvested shares Current Fiscal Year End Date Current Fiscal Year End Date Schedule of Long-Term Debt Instruments [Table] Document Quarterly Report Document Quarterly Report Other Cost and Expense, Operating Other operating expenses Other operating expenses Fair Value, by Balance Sheet Grouping [Table] Fair Value By Balance Sheet Grouping [Table] Entity Address, State or Province Entity Address, State or Province Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Nonvested Shares, Outstanding at Ending Balance Nonvested Shares, Outstanding at Beginning Balance Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Stock Purchase Agreement. Stock Purchase Agreement [Member] Stock Purchase Agreement Shares issued, withheld to cover taxes Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Stock Issued During Period, Value, Stock Options Exercised Option exercises Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued and Other Current Liabilities Other Comprehensive Income (Loss), Net of Tax [Abstract] Other comprehensive income (loss): Subsequent Event [Member] Subsequent Event Impact of change in fair value disclosure. Impact Of Change In Fair Value Disclosure Impact of change in fair value Antidilutive Securities [Axis] Antidilutive Securities Options, Expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Vested or expected to vest at March 31, 2026, Aggregate Intrinsic Value Purchase Commitment, Excluding Long-Term Commitment [Axis] Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Summary of Share-based Compensation Expense Related Party Transaction [Axis] Related Party Transaction AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) Cash and Cash Equivalents [Domain] Cash and Cash Equivalents Convertible promissory note. Convertible Promissory Note [Member] Convertible Promissory Note Minimum [Member] Minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Granted, Weighted Average Grant Date Fair Value Segment Reporting [Abstract] Business and Liquidity Disclosure. Business and Liquidity Disclosure [Line Items] Stock Repurchased and Retired During Period, Value Share retirement Related Party Transactions [Abstract] Accrued and unpaid interest balance. Accrued and Unpaid Interest Balance Accrued and unpaid interest balance Exercise of stock options and employee share purchases Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan Stock issued during period value stock options exercised and employee stock purchase plan. Shares, Outstanding Ending Balance, Shares Beginning Balance, Shares Exercise Price Per Share Included In Approved Repricing Exercise price per share included in approved repricing. Exercise price per share included in approved repricing Commitments and Contingencies Commitments and contingencies Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Outstanding at Ending Balance, Weighted Average Grant Date Fair Value Outstanding at Beginning Balance, Weighted Average Grant Date Fair Value General and Administrative Expense [Member] General and Administrative Reverse stock split description Stockholders' Equity, Reverse Stock Split Category of Item Purchased [Axis] Category of Item Purchased Interest income, net Interest Income (Expense), Net, Total Interest Income (Expense), Operating Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Weighted Average Number of Shares Outstanding, Basic Weighted average number of common shares outstanding, basic Weighted Average Number of Shares Outstanding, Basic, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Exercisable at March 31, 2026, Aggregate Intrinsic Value Due to related party. Due To Related Party Due to related parties Share-Based Payment Arrangement, Plan Modification, Incremental Cost Total expected incremental share-based compensation expense Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Interest Income Interest income. Interest income Proceeds from sale of shares in private placement Proceeds from Issuance of Private Placement Subsequent Events [Text Block] Subsequent Events Related Party Transactions Disclosure [Text Block] Related Party Transactions Debt Instrument, Interest Rate Terms Convertible debt, interest rate terms Share Based Compensation Arrangement by Share Based Payment Award Plan Modification Vested Awards Share based compensation arrangement by share based payment award plan modification vested awards. Share based payment award plan modification vested awards Total stockholders' deficit Equity, Attributable to Parent Ending Balance Beginning Balance New Intercompany Service Agreement. New Intercompany Service Agreement [Member] New Intercompany Service Agreement Related party note. Related party note Related party note Statement of Stockholders' Equity [Abstract] Schedule of Nonvested Share Activity [Table Text Block] Summary of Non-vested Stock Activity Treasury Stock, Common [Member] Treasury Stock Entity Address, Address Line Two Entity Address, Address Line Two Fair Value Disclosures [Text Block] Fair Value Measurement Purchase agreement. Purchase Agreement [Member] Purchase Agreement Schedule of Accrued Liabilities [Table Text Block] Summary of Accrued liabilities Debt Instrument, Name [Domain] Other Assets, Current Other current assets Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Business and liquidity. Business And Liquidity [Abstract] Plan Name [Domain] Non-vested shares. Non Vested Shares [Member] Non-Vested Shares Interest Expense, Operating and Nonoperating Interest Expense, Operating and Nonoperating, Total Interest expense Percentage value of common stock sold in initial public offering. Percentage Value Of Common Stock Sold In Initial Public Offering Percentage value of common stock sold in initial public offering Accrued contract manufacturing expense current. Accrued Contract Manufacturing Expense Current Contract manufacturing costs Related and Nonrelated Parties [Axis] Related Party Entity Address, City or Town Entity Address, City or Town Unusual Risk or Uncertainty, Nature [Axis] Number of Reportable Segments Number of reportable segment Security Exchange Name Security Exchange Name External expenses External Expenses External expenses Business And Liquidity Disclosure [Table] Business And Liquidity Disclosure. Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Options, Vested or expected to vest at March 31, 2026 Antidilutive Securities, Name [Domain] Antidilutive Securities, Name Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash and cash equivalents, end of period Cash and cash equivalents, beginning of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total Interest Paid, Excluding Capitalized Interest, Operating Activity Cash paid for interest Statistical Measurement [Domain] Statistical Measurement Assets, Current Total current assets Share-Based Payment Arrangement, Expense Total share-based compensation expense Document Period End Date Document Period End Date Minimum value of listed securities regain compliance period. Minimum Value of Listed Securities Regain Compliance Period Minimum value of listed securities regain compliance period Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Exercisable at March 31, 2026 Accrued Salaries, Current Payroll Statement of Financial Position [Abstract] Antidilutive Security, Excluded EPS Calculation [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Qualified financing terms. Qualified Financing Terms Qualified financing terms Shares issued, payment for employee bonuses, net of shares withheld for taxes Stock Issued During Period, Shares, Employee Benefit Plan Net of Shares Withheld for Taxes Stock issued during period, shares, employee benefit plan net of shares withheld for taxes. Nasdaq MVLS notice. Nasdaq MVLS Notice [Member] Nasdaq MVLS Notice Interest accrued on related party note. Interest accrued on related party note Interest accrued on related party note Research Services. Research Services [Member] Research Services Cash and Cash Equivalent [Table] Schedule Of Cash And Cash Equivalents [Table] Percentage of per share price of equity securities sold in qualified financing. Percentage of Per Share Price of Equity Securities Sold in Qualified Financing Percentage of per share price of equity securities sold in qualified financing Weighted Average Number of Shares Outstanding, Diluted, Total Weighted Average Number of Shares Outstanding, Diluted Weighted average number of common shares outstanding, diluted Securities Act File Number Entity File Number Cover [Abstract] Related party note Related Party Note Current Related party note current. Treasury stock issued during period shares employee benefit plan. Treasury Stock Issued During Period Shares Employee Benefit Plan Issuance of shares for certain employee bonuses, treasury shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Nonvested Shares, Forfeited Cash and Cash Equivalents Disclosure [Text Block] Cash and Cash Equivalents Number of Operating Segments Number of business segment Sale of Stock [Domain] Segment Reporting Disclosure [Text Block] Segments General and administrative General and Administrative Expense General and Administrative Expense, Total Revenue recognized Revenue from Contract with Customer, Including Assessed Tax Subsequent Event [Table] Business Services and Occupancy Costs. Business Services And Occupancy Costs [Member] Business Services and Occupancy Costs Purchase of treasury shares to satisfy tax withholdings. Purchase Of Treasury Shares To Satisfy Tax Withholdings Payment for shares to satisfy tax withholdings Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Vested or expected to vest at March 31, 2026, Weighted Average Exercise Price Period of license agreement. Period Of License Agreement Period of license agreement New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Stock option, vesting period Depreciation Depreciation Depreciation, Total Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Unrecognized share-based compensation expense related to non-vested shares Document Transition Report Document Transition Report Accrued Liabilities, Current [Abstract] Research and Development Expense Research and development Research and Development Expense, Total Statement of Cash Flows [Abstract] Stock Issued During Period, Value, New Issues Maximum aggregate offering price Shares sold at the market Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary of Option Activity Equity Equity [Text Block] Retirement of treasury shares Retirement of treasury shares. Retirement of treasury shares related to employee withholding, share Earnings Per Share [Text Block] Net Loss Per Share Contingencies Disclosure [Text Block] Contingencies Net loss Net loss Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Outstanding at March 31, 2026, Aggregate Intrinsic Value Sale of shares in private placement Sale Of Shares In Private Placement Sale of shares in private placement. Percentage of service cost. Percentage Of Service Cost Percentage of service cost Assets [Abstract] ASSETS Research and Development Arrangement [Member] Research and Development Agreement Document Fiscal Year Focus Document Fiscal Year Focus Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Cash flows from investing activities: Accounts Payable, Current Accounts payable Accounts Payable, Current, Total Research and Development Expense [Member] Research and Development Accounting Standards Update and Change in Accounting Principle [Abstract] Agenus Inc. Agenus Inc [Member] Agenus Inc Wolf, Greenfield & Sachs, P.C. Wolf, Greenfield & Sachs, P.C. [Member] Wolf, Greenfield & Sachs, P.C. Convertible Debt, Total Convertible Debt Outstanding principal amount of Note Convertible debt outstanding amount Other Liabilities Other Liabilities, Total Other Fair Value Disclosures [Abstract] Other liabilities, current. Other Liabilities Current [Line Items] Other Liabilities Current [Line Items] Debt Instrument [Axis] Share-Based Payment Arrangement [Abstract] Sale of Stock [Axis] Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash used in investing activities Title of 12(b) Security Title of 12(b) Security Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Forfeited, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Forfeited, Weighted Average Grant Date Fair Value Money Market Funds [Member] Institutional Money Market Funds Related and Nonrelated Parties [Domain] Related Party Period for breach of payment obligations. Period For Breach Of Payment Obligations Period for breach of payment obligations Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding at Ending Balance, Weighted Average Exercise Price Outstanding at Beginning Balance, Weighted Average Exercise Price Additional Paid-in Capital [Member] Additional Paid-In Capital Stock Issued During Period, Value, Issued for Services Issuance of shares for services Statement of Income Location, Balance [Axis] Income Statement Location Trading Symbol Trading Symbol Related Party Transaction [Table] Schedule Of Related Party Transactions By Related Party [Table] Subsequent Event Type [Axis] Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Cash flows from financing activities: Entity Ex Transition Period Entity Ex Transition Period Equity Components [Axis] Equity Components Terminate license agreement period. Terminate License Agreement Period Terminate license agreement period Sale of shares in private placement, Shares Sale Of Shares In Private Placement Shares Sale of shares in private placement shares. Equity Component [Domain] Equity Component Accrued research services current. Accrued Research Services Current Research services Number of shares issued Stock Issued During Period, Shares, Employee Stock Purchase Plans Employee share purchases, Shares Maximum [Member] Maximum Statistical Measurement [Axis] Statistical Measurement Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercised, Weighted Average Exercise Price Prepaid expenses Prepaid Expense, Current Prepaid Expense, Current, Total Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Accrued liabilities and other current liabilities Common Stock, Value, Issued Common stock, par value $0.00001 per share; 150,000,000 shares authorized; 4,968,794 and 4,706,246 shares issued at March 31, 2026 and December 31, 2025, respectively Operating Income (Loss) [Member] Operating Expenses Cash and Cash Equivalents [Abstract] Stock Issued During Period, Value, Employee Benefit Plan Issuance of shares for certain employee bonuses Cash and Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Other Nonoperating Income (Expense) [Abstract] Other income (expense), net: Other income (expense): Minimum value of listed securities period. Minimum Value of Listed Securities Period Number of trading days Percentage of computation of interest. Percentage Of Computation Of Interest Percentage of computation of interest Related Party Transaction, Description of Transaction Related party transaction, description Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] Related Party Transaction [Line Items] Related Party Transaction [Line Items] 2021 Employee Stock Purchase Plan Employee Stock [Member] Entity Registrant Name Entity Registrant Name Modified Awards [Member] Modified awards. Modified Awards Exercise price of options repriced Exercise price of options repriced. Other Nonoperating Income (Expense) Other Nonoperating Income (Expense), Total Other income (expense), net Individual Services. Individual Services [Member] Individual Services Subsequent Events [Abstract] Aggregate purchase price Proceeds from Issuance of Common Stock Proceeds from sales of common stock Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Issuance of related party note, Shares Share Adjustment To Additional Paid In Capital Issuance Of Related Party Note Share adjustment to additional paid-in capital issuance of related party note. Two Thousand and Twenty One E I P [Member] Two thousand and twenty one E I P. 2021 Equity Incentive Plan Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated other comprehensive loss Payments to Acquire Property, Plant, and Equipment Purchases of plant and equipment Payments to Acquire Property, Plant, and Equipment, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Nonvested Shares, Granted Assets Total assets Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Exercisable at March 31, 2026, Weighted Average Remaining Contractual Term Income Statement [Abstract] Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value Option Repayable advance received. Repayable Advance Received Repayable advance received Legal services fee Legal Fees Sale of Stock, Number of Shares Issued in Transaction Aggregate number of shares issued and sold Number of shares sold Stock Issued During Period, Shares, New Issues Initial public offering, net of offering costs, shares Shares sold at the market, Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Nonvested Shares, Vested Earnings Per Share, Diluted, Total Earnings Per Share, Diluted Diluted net loss per common share Schedule of Segment Reporting Information, by Segment [Table Text Block] Summary of Selected Financial Information Related to the Company's Single Reportable Segment Purchase Commitment, Excluding Long-Term Commitment [Domain] City Area Code City Area Code Debt Instrument, Issued, Principal Convertible debt issued, principal amount Other Comprehensive Income (Loss), Net of Tax Other Comprehensive Income (Loss), Net of Tax, Total Other comprehensive loss Debt Instrument, Face Amount Principal balance of note Outstanding principal amount of Note Increasing amount of borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Other Income (Expense), Net. Other Income Expense Net [Member] Other Income (Expense), Net Employee share purchases Stock Issued During Period, Value, Employee Stock Purchase Plan Reverse stock split ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Shares issued, vesting of non-vested stock Vesting of nonvested shares, Shares Stock Issued During Period, Shares, Restricted Stock Award, Gross convertible affiliated note. Convertible Affiliated Note [Member] Convertible Affiliated Note Property, Plant and Equipment, Net Property, Plant and Equipment, Net, Total Equipment, net of accumulated depreciation of $647,801 and $612,245 at March 31, 2026 and December 31, 2025, respectively Operating Income (Loss) Operating loss Retained Earnings [Member] Accumulated Deficit Shares issued, payment for employee bonuses Stock Issued During Period, Shares, Employee Benefit Plan Issuance of shares for certain employee bonuses, shares Cash and Cash Equivalents [Axis] Cash and Cash Equivalents Share-Based Payment Arrangement, Noncash Expense Share-based compensation Share-Based Payment Arrangement, Noncash Expense, Total Proceeds from issuance of related party note. Proceeds from issuance of related party note Proceeds from issuance of related party note Class of Stock [Line Items] Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash provided by (used in) financing activities Intercompany allocation included in expense. Intercompany Allocation Included in Expense Intercompany allocation included in expense Proceeds from employee stock purchases and option exercises Proceeds From Employee Stock Purchases And Option Exercises Proceeds from employee stock purchases and option exercises. Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Anti-dilutive Securities Entity Interactive Data Current Entity Interactive Data Current Statement of Income Location, Balance [Domain] Income Statement Location Other Income, Net Other Income [Member] Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Cash flows from operating activities: Accounting Standards Update and Change in Accounting Principle [Text Block] Recent Accounting Pronouncements Minimum value of listed securities for ten trading days Minimum value of listed securities for ten trading days. Minimum Value of Listed Securities for Ten Trading Days Cash Equivalents, at Carrying Value Cost Cash Equivalents, at Carrying Value, Total Issuance of shares for services, shares Stock Issued During Period, Shares, Issued for Services Entity Tax Identification Number Entity Tax Identification Number Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Effect of exchange rate changes on cash Proceeds from Issuance or Sale of Equity Proceeds from Issuance or Sale of Equity, Total Net proceeds from sale of equity Local Phone Number Local Phone Number Work order received from related party. Work Order Received From Related Party Work order received from related party Related Party Transaction [Domain] Related Party Transaction Other Liabilities, Current Other current liabilities Other current liabilities Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Unrecognized share-based compensation expense related to stock options Accounting Policies [Abstract] Stock Issued During Period, Shares, Restricted Stock Award, Forfeited Forfeiture of restricted stock, shares Labor and Related Expense Payroll related expenses Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted average period of unrecognized share-based compensation expense Accrued Professional Fees, Current Professional fees Stock, Class of Stock [Table] Entity Emerging Growth Company Entity Emerging Growth Company Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Modified awards, term Vested or expected to vest at March 31, 2026, Weighted Average Remaining Contractual Term